about
Three-dimensional cage-like microscaffolds for cell invasion studiesp140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation.PI3K class II α controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium functionKRIT1 loss of function causes a ROS-dependent upregulation of c-JunTransport across the cell-membrane dictates nanoparticle fate and toxicity: a new paradigm in nanotoxicology.Super-resolution fluorescence imaging of biocompatible carbon dots.Platinum nanoparticles in nanobiomedicine.Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway.PI3K class II α: a novel regulator of vesicular trafficking at the base of the primary cilium.Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model.Function and expression study uncovered hepatocyte plasma membrane ecto-ATP synthase as a novel player in liver regeneration.Curcumin bioavailability from oil in water nano-emulsions: In vitro and in vivo study on the dimensional, compositional and interactional dependence.Multifunctional Platinum@BSA–Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous MalformationBoron dipyrromethene (BODIPY) functionalized carbon nano-onions for high resolution cellular imagingNegligible particle-specific toxicity mechanism of silver nanoparticles: the role of Ag+ ion release in the cytosolMonocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP-43 subcellular distributionDirectional Immobilization of Proteins on Gold Nanoparticles Is Essential for Their Biological Activity: Leptin as a Case StudyIntracellular Antioxidant Activity of Biocompatible Citrate-Capped Palladium Nanozymes
P50
Q27308981-18437089-743A-4887-85F7-88E29D08E544Q30010279-5C0C9A2B-7B93-489E-9921-1DC4FA6E6968Q33701751-C47962A4-D76F-43B3-81A3-D706A452E098Q38873324-EC4E85B2-5C5F-4088-8F33-919B8A51E050Q38971783-118130F0-1927-4775-87B6-60E99A554474Q38979127-0F60B822-02EB-432C-87A3-6A44EEA08337Q39428343-64B02C2A-FC35-4BD7-BE16-5D389EF5D70FQ42811747-C43E6ED0-A39D-4050-94D7-24893B1D58B6Q46535392-55F7929B-B838-4EB6-A16E-3766AB3C797DQ46604327-27B836FC-B2DE-4E68-968B-014BF1A8584BQ51708931-EC458C86-096B-456D-A7D3-5D5A4B9E193CQ53106218-365671D9-5883-4A2C-AFE7-085C445DF364Q59808061-7B372D05-9FD1-4F24-BEC7-11071D7A6DF3Q60621919-83C762B1-566D-4D0B-B0A5-F11114E0D740Q86421732-B0E33BBA-265E-44ED-8C4F-CF4766EFFB6CQ89197137-CD6AB620-D23F-4652-BD80-108DA8694165Q92084001-D6EC2AE5-12DC-4F8D-A4E5-62C7005D285EQ92703735-0D4DF02E-88E2-42C0-AFC1-D8A160D14E8C
P50
description
investigador
@es
researcher
@en
name
E De Luca
@en
type
label
E De Luca
@en
prefLabel
E De Luca
@en
P31
P496
0000-0001-9849-0703